T32 GI/Liver Fellow, University of Southern California Clinical epidemiology, steatotic liver disease

Joined February 2024
Matt Dukewich, MD, PharmD retweeted
Multi-center ACCELERATE study led by USC GI fellow @MDukewich shows re-abstinence after alcohol relapse among LT recipients for AH can restore survival similar to w/o alcohol relapse. -Take home message: detect early and treat relapse aggressively! journals.lww.com/ajg/abstrac…
1
3
13
1,166
RT @IASatUSC: Happy Friday Everyone! Congratulations to all of our ECASS 2024 participants and winners. What an amazing day full of novel a…
1
60
Matt Dukewich, MD, PharmD retweeted
5
9
7
71
17,327
Matt Dukewich, MD, PharmD retweeted
How big a problem is post LT EtOH use? @USC_KeckGILiver Drs. Brian P Lee and Matt Dukewich @MDukewich report data from the accelerate cohort: 80% pts remain abstinent post LT, of the 20% that relapse those that re-abstain and stop drinking for 12m after one relapse have good outcomes. Addiction is a chronic disease and we need to keep reinforcing the importance of #abstinence @CLDFoundation #liverconnect @KeckMedicineUSC #livertwitter #gitwitter @AyyalaDivya @norahterrault @HelenHanMD @JeffreyAKahn @melanie_a_hundt @howiethedoc @kalizhouMD @AniKardashianMD – at Scottsdale, AZ
2
4
28
1,849